RBC Capital Markets Raises Price Target on Repligen Corporation
RBC Capital Markets increased its price target for Repligen Corporation from $185 to $200 while maintaining an "Outperform" rating.
Stocks · News reference
Canaccord Genuity Maintains Hold on Repligen, Raises Price Target to $180
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Repligen Q3 2026 Earnings Call Transcript
Repligen (NASDAQ:RGEN) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. For
Repligen Reports Third Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance
Repligen Corporation reported third-quarter 2026 revenue of $209 million and raised its full-year 2026 revenue guidance to $844–$852 million.
8-K filing — REPLIGEN CORP (RGEN)
Filed: 2026-10-27 AccNo: 0001628280-26-067405 Size: 547 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits